AEMD
AEMD
Positions held
Your positionsAEMD isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-17 · BC-Most Active Stocks
2026-09-17 · Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger
2026-09-17 · North Immunology joins biotech reverse merger boom with Aethlon deal
2026-08-28 · BC-Most Active Stocks
2026-08-19 · AEMD: Oncology Study Advances; Cost-Efficient Preclinical Activities Regarding Other Diseases Continue
2026-08-18 · Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
2026-08-14 · Aethlon Medical, Inc. Q1 2027 Earnings Call Summary
2026-08-13 · Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
2026-08-05 · Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
2026-07-15 · Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream
Price (daily)
Full chart · RSI · MACD · patterns